Fill Finish Manufacturing Market Segmentation by Design (Single-Chamber, Dual-Chamber, and Customized Prefilled Syringes); by Usability Type (Disposable, and Reusable); by Packaging Type (Glass, and Plastic Prefilled Syringes); by Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Vaccine, Biopharmacy, Antithrombotic, and Others); by Combination Products (Single Entity, Co-Packaged, and Cross-Labeled Combination Products); and by End-User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Pharmaceutical Companies)-Global Demand Analysis & Opportunity Outlook 2021-2031
16 Feb 2022
Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022...
The Research Report is Updated with 2021 Base Year, 2022 Estimated year and Forecast till 2031 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2021 as base year, 2022 as estimated year and forecast to 2031. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Global Fill Finish Manufacturing Market Highlights Over 2021 - 2031
The global fill finish manufacturing market is estimated to garner a revenue of USD 15828.8 Million by the end of 2031 by growing at a CAGR of 10.70% over the forecast period, i.e., 2022 – 2031. Moreover, in the year 2021, the market generated a revenue of USD 5762.0 Million. The growth of the market can primarily be attributed to the rising incidences of different types of chronic diseases globally, which is driving the need for different types of advanced medicines to treat these diseases. For instance, the prevalence of the chronic disease, diabetes, in the year 2019, was known to be the ninth leading cause of death, according to the statistics by the World Health Organization (WHO). Moreover, in the same year, around 1.5 Million people were known to die due to the chronic disease. Further, the rise in adoption of self-injecting parental drug devices is also expected to drive the market growth in the coming years. Prefilled syringes and injection devices are gaining strong acceptance as delivery systems for injectable drugs. These are mainly used to treat chronic conditions where patients are required to self-administer their medications. With the rise in adoption of parenteral drugs, especially biologics, there is a growing need among pharmaceutical drug manufacturers to design more sophisticated container closure and drug delivery systems, which is anticipated to drive the market growth.
On the other hand, the increasing advancements in the field of drug delivery systems, backed by the rising healthcare expenditure globally, and the surge in investments for research and developments in the field of advanced medications for different types of diseases, are also expected to drive the market growth. Besides this, it is also expected that with the development of COVID-19 vaccines to treat SARS-CoV-2 infections, these vaccines may migrate to a single-dose prefilled syringe to reduce waste and avoid the expiry of unused vaccine doses. Such a factor is also anticipated to drive the growth of the market in the coming years.
Global Fill Finish Manufacturing Market Regional Synopsis
Regionally, the global fill finish manufacturing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe is anticipated to garner the largest revenue of USD 6004.7 Million by the end of 2031, by growing from a revenue of USD 2425.8 Million in the year 2021. The growth of the market in the region can primarily be attributed to the presence of several pharmaceutical drug manufacturers and their focus on developing advanced drug delivery systems. The pharmaceutical industry in Europe is also one of the largest industries in the world, in terms of value of production and exports. According to the statistics by the European Federation of Pharmaceutical Industries and Associations (efpia), the value of production of the pharmaceutical industry in Europe registered USD 118642.47 Million in the year 2000, and was estimated to reach a value of USD 380401 Million by the end of 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherland, and the Rest of Europe. Out of these, the market in Germany is anticipated to garner the largest revenue of USD 1208.5 Million by the end of 2031, up from a revenue of USD 443.9 Million in the year 2021.
Growth Drivers and Challenges Impacting the Growth of the Global Fill Finish Manufacturing Market
Growing Adoption of Self-Injecting Parental Devices
Increasing Demand for Pre-Filled Syringes for COVID-19 Vaccines
Risks Associated with the Packaging of Pre-Filled Syringes
Availability of Lose-Cost Alternative
Global Fill Finish Manufacturing Market Segmentation Synopsis
The global fill finish manufacturing market is segmented by design into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Out of these, the single-chamber prefilled syringes segment is anticipated to generate the largest revenue of USD 11233.1 Million by the end of 2031, up from a revenue of USD 4142.3 Million in the year 2021. By usability type, the market is segmented into disposable and reusable, out of which the disposable segment is anticipated to garner the largest revenue by the end of 2031 and also grow with the highest CAGR of 10.82% during the forecast period. By packaging type, the market is segmented into glass prefilled syringes, and plastic prefilled syringes, out of which, the glass prefilled syringes segment is anticipated to garner the largest revenue by the end of 2031. By application, the market is segmented into diabetes, anaphylaxis, rheumatoid arthritis, vaccine, biopharmacy, antithrombotic, and others. Out of these, the vaccine segment is anticipated to garner the largest revenue of USD 3505.9 Million by the end of 2031, up from a revenue of USD 1224.9 Million in the year 2021. By combination products, the market is segmented into single entity combination products, co-packaged combination products, and cross-labeled combination products. Out of these, the single entity combination products segment is anticipated to garner the largest revenue of USD 7402.5 Million by the end of 2031, up from a revenue of USD 2682.6 Million in the year 2021. By end-user the market is segmented into contract manufacturing organizations, biopharmaceutical companies, and pharmaceutical companies. Out of these, biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 6906.3 Million by the end of 2031, up from a revenue of USD 2469.7 Million in the year 2021.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global fill finish manufacturing market that are included in our report are Becton, Dickinson and Company, B. Braun Melsungen AG, Catalent, Inc., AbbVie Inc., Baxter International Inc., Gerresheimer AG, Medefil, Inc., SCHOTT AG, West Pharmaceutical Services, Inc., MedXL Inc., NIPRO Corporation, Terumo Corporation, Taisei Kako Ltd., Otsuka Pharmaceutical Factory, Inc., and others.
Latest Developments in the Global Fill Finish Manufacturing Market:
December 2nd, 2020: BD (Becton, Dickinson and Company) announced that over a period of four years, the company would invest around USD 1.2 Billion across its six global manufacturing locations to expand and upgrade the manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS). The investment would also include adding a new manufacturing facility in Europe.
June 25th, 2020: Catalent, Inc. announced that it has collaborated with Moderna, Inc. for large-scale commercial fill-finish manufacturing of the mRNA-based COVID-19 vaccine candidate (mRNA-1273) of Moderna at the biologics facility of Catalent in Bloomington, Indiana.
Key Reasons to Buy Our Report
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
The report includes detailed company profiles of the major players dominating the market.
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
FREQUENTLY ASKED QUESTIONS
The growing adoption of self-injecting parental devices, along with the increasing demand for pre-filled syringes for COVID-19 vaccines are some of the major factors anticipated to drive the market growth.
The market is anticipated to attain a CAGR of 10.70% over the forecast period, i.e., 2022-2031.
The risks associated with the packaging of pre-filled syringes, and the availability of lose-cost alternative are estimated to hamper the market growth.
Which region will provide more business opportunities for growth of fill finish manufacturing market in future?
The market in Europe is anticipated to garner the largest revenue of USD 6004.7 Million by the end of 2031 and provide more business opportunities in the future.
The major players in the market are Becton, Dickinson and Company, B. Braun Melsungen AG, Catalent, Inc., AbbVie Inc., Baxter International Inc., Gerresheimer AG, Medefil, Inc., SCHOTT AG, West Pharmaceutical Services, Inc., and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by design, usability type, packaging type, application, combination products, end-user, and by region.
Which segment captures the largest market size in design segment in the fill finish manufacturing market?
The single-chamber prefilled syringes segment is anticipated to generate the largest revenue of USD 11233.1 Million by the end of 2031 and display significant growth opportunities.
1. Market Definition
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary – Fill Finish Manufacturing Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Regulatory & Standards Landscape
9. Industry Risk Analysis
10. Pricing Analysis
11. Value Chain Analysis
12. Design Analysis of Pre-Filled Syringe
13. Product Feature Analysis
14.Industry Growth Outlook
15. Competitive Positioning
16.1. Market Share Analysis, 2021
16.2. Competitive Benchmarking
16.3. Company Profiles
16.3.1. Becton, Dickinson and Company
16.3.2. B. Braun Melsungen AG
16.3.3. Catalent, Inc.
16.3.4. AbbVie Inc.
16.3.5. Baxter International Inc.
16.3.6. Gerresheimer AG
16.3.7. Medefil, Inc.
16.3.8. SCHOTT AG
16.3.9. West Pharmaceutical Services, Inc.
16.3.10. MedXL Inc.
16.3.11. NIPRO Corporation
16.3.12. Terumo Corporation
16.3.13. Taisei Kako Ltd.
16.3.14. Otsuka Pharmaceutical Factory, Inc.
17. Global Fill Finish Manufacturing Market 2021-2031
17.1. Market Overview
17.2. By Value (USD Million)
17.3. Segmentation Analysis
17.3.1. By Design
22.214.171.124. Single-Chamber Prefilled Syringe
126.96.36.199. Dual-Chamber Prefilled Syringe
188.8.131.52. Customized Prefilled Syringe
17.3.2. By Usability Type
17.3.3. By Packaging Type
184.108.40.206. Glass Prefilled Syringes
220.127.116.11. Plastic Prefilled Syringes
17.3.4. By Applications
18.104.22.168. Rheumatoid Arthritis
17.3.5. By Combination Products
22.214.171.124. Single Entity Combination Products
126.96.36.199. Co-Packaged Combination Products
188.8.131.52. Cross-Labeled Combination Products
17.3.6. By End-User
184.108.40.206. Contract Research Organizations (CROs)
220.127.116.11. Biopharmaceutical Companies
18.104.22.168. Pharmaceutical Companies
17.3.7. By Region
22.214.171.124. North America
126.96.36.199. Asia Pacific
188.8.131.52. Latin America
184.108.40.206. Middle East & Africa
18. North America Fill Finish Manufacturing Market 2021-2031
18.1. Market Overview
18.2. By Value (USD Million)
18.3. Segmentation Analysis
18.3.1. By Design
220.127.116.11. Single-Chamber Prefilled Syringe
18.104.22.168. Dual-Chamber Prefilled Syringe
22.214.171.124. Customized Prefilled Syringe
18.3.2. By Usability Type
18.3.3. By Packaging Type
126.96.36.199. Glass Prefilled Syringes
188.8.131.52. Plastic Prefilled Syringes
18.3.4. By Applications
184.108.40.206. Rheumatoid Arthritis
18.3.5. By Combination Products
220.127.116.11. Single Entity Combination Products
18.104.22.168. Co-Packaged Combination Products
22.214.171.124. Cross-Labeled Combination Products
18.3.6. By End-User
126.96.36.199. Contract Research Organizations (CROs)
188.8.131.52. Biopharmaceutical Companies
184.108.40.206. Pharmaceutical Companies
18.3.7. By Country
220.127.116.11. United States
19.Europe Fill Finish Manufacturing Market 2021-2031
19.1. Market Overview
19.2. By Value (USD Million)
19.3. Segmentation Analysis
19.3.1. By Design
19.3.2. By Usability Type
19.3.3. By Packaging Type
19.3.4. By Applications
19.3.5. By Combination Products
19.3.6. By End-User
19.3.7. By Country
18.104.22.168. United Kingdom
22.214.171.124. Rest of Europe
20. Asia Pacific Fill Finish Manufacturing Market 2021-2031
20.1. Market Overview
20.2. By Value (USD Million)
20.3. Segmentation Analysis
20.3.1. By Design
20.3.2. By Usability Type
20.3.3. By Packaging Type
20.3.4. By Applications
20.3.5. By Combination Products
20.3.6. By End-User
20.3.7. By Country
126.96.36.199. South Korea
188.8.131.52. Rest of APAC
21. Latin America Fill Finish Manufacturing Market 2021-2031
21.1. Market Overview
21.2. By Value (USD Million)
21.3. Segmentation Analysis
21.3.1. By Design
21.3.2. By Usability Type
21.3.3. By Packaging Type
21.3.4. By Applications
21.3.5. By Combination Products
21.3.6. By End-User
21.3.7. By Country
184.108.40.206. Rest of LATAM
22. Middle East & Africa Fill Finish Manufacturing Market 2021-2031
22.1. Market Overview
22.2. By Value (USD Million)
22.3. Segmentation Analysis
22.3.1. By Design
22.3.2. By Usability Type
22.3.3. By Packaging Type
22.3.4. By Applications
22.3.5. By Combination Products
22.3.6. By End-User
22.3.7. By Country
220.127.116.11. South Africa
18.104.22.168. Rest of MEA
Please enter your personal details below
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Catalent, Inc.
- AbbVie Inc.
- axter International Inc.
- Gerresheimer AG
- Medefil, Inc.
- SCHOTT AG
- West Pharmaceutical Services, Inc.
- MedXL Inc.
- NIPRO Corporation
- Terumo Corporation
- Taisei Kako Ltd.
- Otsuka Pharmaceutical Factory, Inc.